During the past decade, ICM, CIC Neurosciences conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ICM, CIC Neurosciences" are "Parkinson's Disease" (1 trials) and "Stroke and Healthy Subjects" (1 trials). Many other conditions were trialed in "ICM, CIC Neurosciences" in a lesser frequency.

Most popular intervention types in "ICM, CIC Neurosciences" are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PAS" (1 trials) and "Serious game" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICM, CIC Neurosciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "ICM, CIC Neurosciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in ICM, CIC Neurosciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ICM, CIC Neurosciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".